Drug Patent Suits' Novel Theory Tests False Claims Act Limits
A string of unusual False Claims Act actions could set the federal courts of appeals on a collision course and create risks for patent holders beyond Congress' contemplation....To view the full article, register now.
Already a subscriber? Click here to view full article